SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-001345
Filing Date
2019-02-20
Accepted
2019-02-20 07:00:45
Documents
2
Period of Report
2019-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_021419.htm 8-K 26842
2 PRESS RELEASE ex99-1.htm EX-99.1 16925
  Complete submission text file 0001387131-19-001345.txt   45135
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 19617057
SIC: 2834 Pharmaceutical Preparations